Blocked blood vessels can complicate medical conditions that may result in fatality. As a result, artificial blood vessels are used to replace these damaged blood vessels. Artificial blood vessels refer to tubes made from various synthetic materials in order to restore and normalize blood circulation during disease conditions. They are mainly used to substitute aorta and are connected to two ends of blood vessels. These artificial blood vessels comprises biosynthetic materials like Polydioxanone and polyethylene terephthalate, due to mechanical properties such as high resistance against water and chemical, high oxygen permeability and high conductivity.
Hemoglobin-based oxygen carriers being commonly used artificial blood vessels, facilitate the transfer of oxygen molecules to heart vessels form the blood stream, thereby aiding in restoration of regular cardiac functioning. Silk has been recently used in manufacturing of artificial blood vessels, with prosthetic silk mostly used and further features alternative silk to provide protective coating, to ensure prevention of blood leakage.
COVID – 19 scenario analysis:
- The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses.
- Industry closures and people are asked to stay in their homes, which has taken a huge toll in terms of money and economic growth.
- Over 4 million people affected globally, with 300 thousand losing their lives due to SARS-CoV-2.
- Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers.
- Due to diversion of medical field toward treating COVID-19, this segment has to face negligence subsequently causing negative impact on the artificial blood vessels market.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
High prevalence of cardiovascular diseases globally, increasing need to bypass grafting procedures and growing adoption of artificial vessels in such medical procedures are the driving factors of the artificial blood vessels market. Arteriosclerotic vascular disorders is one of the major causes leading to fatality in developed regions like the U.S. and Europe. A bypass operation being the only valid solution in such cases and technological advancements in artificial blood vessels that have enabled these vessels to mimic various biological features observed in the natural blood vessels found in the body, which has led to their acceptance and has emerged as an alternative to conventional bypass surgeries that used blood vessels from another part of patient’s body to replace the damaged ones is also augmenting the growth of the market around the world. Artificial blood vessels further reduce the chances of risks and complications associated with transplanting vessels from other parts of a patient's body such as development of arteriosclerosis and other post-surgical complications.
The adoption of artificial blood vessels has various benefits including regulatory compliance, prevention of blood coagulation when in contact with blood, and high resistance to several infections coupled the healing, contracting, remodeling abilities and secretion of byproducts similar to that of natural blood vessel products and it represents these vessels as an ideal vascular graft. These advantages owing to use of artificial blood vessels would surge the implementation of these products. Furthermore, the basic requirements optimal for constructing an artificial vessel are a structural scaffold (preferably made of biodegradable polymer or collagen), a nurturing environment and vascular cells. These requirements are met by artificial blood vessels which also possess the abilities to imitate the vascular cells and do that by creating pulsatile flow. These factors would augment the growth of this market in near future.
On the contrary, stringent regulatory scenario associated with approval of innovative solutions may hamper the market growth. Additionally, high investment related with bypass surgeries and transplants involving artificial blood vessels would further restrain the growth for this market globally.
Rise in aortic diseases to boost the market
Rising prevalence of aortic diseases around the world would ensure growth of the artificial blood vessels market. Aorta being the largest blood vessel in the body, several disorders and medical conditions can damage aorta with aortic aneurysm being most commonly reported aortic disorder. Atherosclerosis, genetic conditions, hypertension, connective tissue ailments, and injury are the other disorders affecting aorta. The growing burden of these diseases will fuel the artificial blood vessels market growth. According to the Centers for Disease Control and Prevention (CDC), aortic aneurysm caused over 17 thousand deaths in 2014, in the U.S.
A report by D. P. J. Howard et al., stated in Wiley Online Library, the cases people suffering from of acute abdominal aortic aneurysm (AAA) per 100,000 patients, annually was 55 in adults aged between 65 and 74 years, and multiplied to 112 for people aged between 75 and 84 years and further soared tremendously at 298 for people belonging to age group 85 years and above. Hence, the prevalence of aortic diseases would propel the market in the future.
North American region dominates the market
North America is expected to lead the artificial blood vessels throughout. The dominance is due to factors such as rise in the prevalence of chronic diseases and higher adoption of technology in the region. According to the Centers for Disease Control and Prevention, cardiac diseases are a leading cause of death in American men. According to the CDC report published in 2019, aortic aneurysms led to 9,928 fatalities in 2017 in the U.S. The growing burden of aortic diseases will facilitate the growth for the artificial blood vessels market. Drastic rise in healthcare expenditure, availability of a well-developed infrastructure and presence of major industry are the other factors fostering the market in the near future.
Key benefits of the report:
- This study presents the analytical depiction of the global artificial blood vessels market along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global artificial blood vessels market share.
- The current market is quantitatively analyzed to highlight the global artificial blood vessels market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global artificial blood vessels market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the artificial blood vessels market research report:
- What are the leading market players active in the artificial blood vessels market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Artificial Blood Vessels Market, by Polymer Type Report Highlights
| Aspects | Details |
 By Polymer Type |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Humacyte Inc.,, Associates and Cook Medical Incorporated., Medtronic plc.,, ArtiCasc 3D,, LeMaitre Vascular Inc.,, Techshot Inc.,, B. Braun Melsungen,, Becton, Dickenson and Company,, Terumo Medical Corporation,, W. L. Gore |
Loading Table Of Content...
